Abstract
Objective
To compare the clinical efficacy of percutaneous vertebroplasty (PVP) alone and microwave ablation (MWA) combined with PVP for the treatment of painful spinal metastases from non-small cell lung cancer (NSCLC).
Methods
From October 2014 to October 2021, the data of 58 NSCLC patients with refractory painful spinal metastases (visual analog scale score ≥ 5) were retrospectively collected and analyzed. Patients in Group A (n = 30) and Group B (n = 28) received PVP alone and MWA combined with PVP, respectively. The primary endpoint was pain relief. The secondary endpoints were quality of life (QoL), local tumor progression (LTP), and complications.
Results
The technical success rate was 100% in both groups. Patients in both groups showed similar pain relief at 1–12 weeks, but patients in Group B still showed sustained pain relief at 24 weeks compared to those in Group A (p = 0.03). The assessment of QoL showed similar changes. LTP (33.00% vs. 7.14%, p = 0.02) and cement leakage rates (40.00% vs. 7.14%, p = 0.03) were lower in Group B. The multivariate analysis demonstrated spinal metastases with a maximum diameter ≤ 3.0 cm (p = 0.027) and MWA combined with PVP (p = 0.028) were two independent protective factors for LTP. For cement leakage, spinal metastases with vertebral body compression (p = 0.019) was an independent risk factor, while MWA combined with PVP (p = 0.042) was an independent protective factor.
Conclusion
MWA combined with PVP for painful spinal metastases from NSCLC performed more sustained pain relief (>6 months) and ultimately improved QoL with lower LTP and cement leakage rates, compared to PVP alone.
Author contributions
Conception and design: Liu YM; Administrative support: Jiao DC and Han XW; Provision of study materials or patients: Jiao DC and Han XW; Collection and assembly of data: Liu YM and Zhang CZ; Data analysis and interpretation: Liu YM, Yuan HY, and Milan S; Manuscript writing: Liu YM; preparing: Liu YM and Milan S; Figure 4–5 preparing: Liu YM and Zhang CZ; All tables preparing: Liu YM; Final approval of manuscript: all authors.
Disclosure statement
No potential conflict of interest was reported by the author(s).
Data availability statement
In addition to the raw data in the manuscript, the datasets used are available from the corresponding author on reasonable request.